معرفی
Dr. Adriaan Kooy is an Associate Professor of Internal Medicine at the Faculty of Medical Sciences, University of Groningen, and a Principal Investigator at the Bethesda Diabetes Research Center. He also serves as an Internist of Vascular Medicine at Treant Care Group, Netherlands. His research focuses on insulin resistance, type 2 diabetes, and vascular outcomes, with a particular emphasis on long-term randomized controlled trials (POEM, HOME, PRIORITY studies) to improve metabolic and cardiovascular health. Additionally, he explores healthy aging and diabetes-related biomarkers.
- External Positions:
- Director and Principal Investigator, Bethesda Diabetes Research Center (2008–present)
- Internist of Vascular Medicine, Treant Care Group (1995–present)
- Research Interests:
- Insulin resistance and its vascular consequences
- Clinical trials in early and advanced diabetes
- Cardiovascular and kidney disease in diabetes
- Healthy aging and biomarker development
- Recent Research Trends:
- 2025: Spironolactone’s role in kidney disease progression
- 2024: Heterogeneity in type 1 diabetes and fetal outcomes from metformin exposure
- 2023: Bempedoic Acid’s cardiovascular impact, drug rotation for albuminuria, and retinopathy as a risk marker
- Collaborations:
- Member, European Association for the Study of Diabetes (2011–present)
- Peer reviewer for British Medical Journal and ZonMw
- Collaborator with Novo Nordisk and Dutch diabetes research networks
- Press/Media:
- Provided expert commentary on diabetes type 2 research funded by Drenthe (2021)
۰مقاله منتشرشده
